Blog

29
Jul

Ksilink, joining academic-industry cell imaging consortium to speed patient-based drug discovery and development

Posted by | No Tags | news | Comments Off on Ksilink, joining academic-industry cell imaging consortium to speed patient-based drug discovery and development

The Joint Undertaking in Morphological Profiling with Cell Painting aims to accelerate drug discovery and development by creating a massive dataset of cells imaged under more than 140,000 different conditions. Credit : Broad Institute of MIT and Harvard. Human cells imaged using Cell Painting are treated with fluorescent dyes that mark different cellular components, including […]

Read More
19
Jun

Promoting young scientists in translational science

Posted by | No Tags | news | Comments Off on Promoting young scientists in translational science

Ksilink is proud to announce that Ms Tiphaine Champetier has successfully passed her PhD viva. Ksilink is engaged in promoting young scientists in translational science and currently supports two other PhD students in collaboration with the Ecole Normale Supérieure and Sorbonne University. Tiphaine was a recipient of an ANRT Cifre fellowship and worked on “Novel […]

Read More
24
May

Ksilink grows and further develops

Posted by | No Tags | news | Comments Off on Ksilink grows and further develops

During the last months Ksilink has welcomed seven new scientists experts in cell biology, drug screening, and image and data mining. “We are happy to have now an outstanding team of 23 staff. Recently Ksilink has strengthen its cell disease modeling, screening capacities, and image analysis by increasing its R&D team with seven new scientists. […]

Read More
01
Nov

New strategic partnership to fight heart disease

Posted by | No Tags | news | Comments Off on New strategic partnership to fight heart disease

On October 29th 2019, Ksilink has initiated two new strategic partnerships with the Biological Adaptation and Ageing research unit of the Institute of Biology Paris Seine (B2A-IBPS, Sorbonne Université/CNRS/Inserm) at the Sorbonne University and with the biotechnological company myriamed, a spinoff of the University Medical Center Göttingen. Both partnerships are pursuing a common goal: to […]

Read More
31
Oct

Change in continuity: Professor Alain Beretz appointed as new Ksilink Chairman

Posted by | No Tags | news | Comments Off on Change in continuity: Professor Alain Beretz appointed as new Ksilink Chairman

On September 24th 2019, Ksilink Board of Directors appointed Professor Alain Beretz (on the left) as new Chairman of the Association, replacing Professor André Syrota (on the right) nominated Honorary Chairman. Please click here to download the press release in English. Please click here to download the press release in French.

Read More
02
Sep

Job posting

Posted by | No Tags | Uncategorized | Comments Off on Job posting

A Pluripotent Stem Cell Biology Research Technician position is available at Ksilink. For more information, please click here.

Read More
24
Apr

New publication in SLAS Discovery

Posted by | No Tags | news | Comments Off on New publication in SLAS Discovery

Dr YongJun Kwon, Ksilink Head of Early Discovery and Technology Development, together with Dr Il Doh from Medical & Bio Device (MBD) Co., Ltd publish a paper entitled “Drug Efficacy Comparison of 3D Forming and Preforming Sphere Models with a Micropillar and Microwell Chip Platform” in SLAS Discovery journal. Ksilink is using such technology and […]

Read More
13
Mar

Come Together Cardiovascular Disease

Posted by | No Tags | news | Comments Off on Come Together Cardiovascular Disease

Ksilink organizes a come together in the field of patient based disease modeling for cardiovascular diseases. Prof Zimmermann from University of Göttingen and Dr. Kirchmeir present the spin off myriamed GmbH, a specialist for standardized engineering of cardiac tissue. Prof. Agbulut from University of Sorbonne is presenting its expertise for Myofibrillar myopathy. Dr. Sinnecker from Technical […]

Read More
28
Feb

Ksilink increases its computing capacity

Posted by | No Tags | news | Comments Off on Ksilink increases its computing capacity

Ksilink acquires one high performance GPU/TPU cluster from locally-based 2CRSI company to implement deep learning approaches to its drug discovery programs for cardiovascular and muscle diseases. Equipped with 4 NVIDIA Tesla V100 Tensor Core delivers up to 125 TeraFlops, the GPU cluster will accelerate AI, high performance computing (HPC), and graphics. In parallel, Ksilink upgrades Checkout, its C++ based […]

Read More
05
Feb

Press Release – Collaboration with I-Stem on ASD and DM1

Posted by | No Tags | news | Comments Off on Press Release – Collaboration with I-Stem on ASD and DM1

Ksilink initiates 2 new drug discovery programs on Muscular Dystrophy-1 (DM1) and Autism Spectrum Disorders (ASD) with its strategic partner I-Stem. Click here to download the press release.

Read More